Document is current
Any future updates will be listed below
-
Authors
Meguro, Shu https://orcid.org/0000-0003-3528-128X
Sakane, Naoki
Hosoda, Kiminori
Hirota, Yushi
Itoh, Arata
Kato, Ken
Kodani, Noriko
Kuroda, Akio
Matsuhisa, Munehide
Miura, Junnosuke
Shimada, Akira
Tone, Atsuhito
Toyoda, Masao
Murata, Takashi
,
Nishimura, Kunihiro
Miyamoto, Yoshihiro
Satoh-Asahara, Noriko
Kouyama, Ryuji
Kasahara, Masato
Kasama, Shu
Suzuki, Shota
Ito, Yukie
Watanabe, Tomokazu
Suganuma, Akiko
Shen, Zhuo
Kobayashi, Hiroko
Takagi, Satoshi
Hoshina, Sari
Shimura, Kanako
Tsuchida, Yukiko
Kimura, Moritsugu
Saito, Nobumichi
Oikawa, Yoichi
Satomura, Atsushi
Haisa, Akifumi
Kawashima, Satoshi
Itoh, Hiroshi
Saisho, Yoshifumi
Irie, Junichiro
Tanaka, Masami
Mitsuishi, Masanori
Nakajima, Yuya
Inaishi, Jun
Kinouchi, Kenichiro
Yamaguchi, Shintaro
Sugiyama, Kazutoshi
Yagi, Kazuma
Tsuchiya, Tami
Shimizu, Ikki
Fukuda, Tetsuya
Kusunoki, Yoshiki
Katsuno, Tomoyuki
Matoba, Yuka
Hitaka, Yumi
Abe, Kentaro
Tanaka, Natsuko
Taniguchi, Ryoko
Nagao, Toshihiko
Hida, Kazuyuki
Iseda, Izumi
Takeda, Masaya
Matsushita, Yuichi
Tenta, Masafumi
Tanaka, Tsuyoshi
Kouyama, Kunichi
Fukunaga, Michiru
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (18ek0210104h0001, 19ek0210104h0002, 20ek0210104h0003)
Japan IDDM network (non available)
- License Information
-
More Information
Article History
Received: 27 April 2024
Accepted: 17 July 2024
First Online: 19 August 2024
Declarations
:
: No potential conflicts of interest (COI) as the ISCHIA Study Group relevant to this article were reported. Potential COI concerning all individual investigators were reviewed by the Certified Review Board in accordance with the Clinical Trials Act []. The COI of the members of the writing group are as follows: YH received lecture fees from Abbott, Eli Lilly, Sanofi, Novo Nordisk, Sumitomo, and Terumo and received a research grant from Sumitomo, Kyowa Kirin, and Medtronic Japan and a donation from Abbott Japan. MM received lecture fees from Abbott, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Orizuru Therapeutics, Sanofi, Sumitomo, and Terumo. SM received lecture fees from Eli Lilly, Kowa, Sumitomo, and Novo Nordisk. JM received lecture fees from Novo Nordisk. AT received lecture fees from Abbott, Eli Lilly, Sanofi, and Terumo. MT received lecture fees from Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Sumitomo, and Mitsubishi Tanabe and received subsidies from Cocokara Fine Healthcare, LifeScan, Roche DC, and Super Light Water. TM received a research grant from Medtronic. KH, KK, AS, AK, NK, NS, and AI declare that they have no conflict of interest.
: Informed consent or an appropriate substitute was obtained from all patients prior to their inclusion in the study. The study protocol was approved by the Certified Review Board (National Hospital Organization Osaka National Hospital: N2018002). Clinical trial registration: jRCT1052180075 (approval date of registry; 26 February 2019).
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and/or with the Helsinki Declaration of 1964 and later versions.
